Skip to content
  • Home
  • World News
  • Business
  • Aviation
195 news

195News

All the news that's fit to print

  • Home
  • World News
  • Business
  • Aviation
  • Toggle search form
  • Wild Goose Filling Releases Gosling 2.0 Beverage Canning System World News
  • Queen of the Most Expensive, creates a Kim Kardashian artwork World News
  • 5G Technologies Global Market Report 2024 Shows Exponential Growth In Market Size At A CAGR Of 51.3% World News
  • Ready-to-Eat Food Market to hit $ 1,471.94Bn by 2028, Globally, by 2028 at 5.4% CAGR: The Insight Partners World News
  • Special Envoy and Coordinator for the Global Engagement Center Rubin’s Travel to London and Brussels World News
  • Coffee Concentrates Market to Achieve $3.6 Billion by 2032 Business
  • Key Driver Transformation in the Nutritional Supplements Market 2024 Business
  • Emery Law Office Hosts Open House To Celebrate Wright Tower Expansion World News

DanCann Pharma in Multi-Level Expansion of Precision Aeroponic Systems to Fulfill Export Contracts

Posted on May 18, 2023 By NewsEditor

DanCann Pharma Aeroponic Veg Roots - Precision Medical Aeroponics

DanCann Pharma Aeroponic Veg Roots – Precision Medical Aeroponics

DanCann Pharma Precision Aeroponic Mecidal Flower for Export

DanCann Pharma Precision Aeroponic Mecidal Flower for Export

DannCann Selects AEssenseGrows To Access Europe GMP

DannCann Selects AEssenseGrows To Access Europe GMP

The Danish Medicinal Cannabis Producer is Scaling AEssenseGrows Systems in Their EU-GMP Certified Facility to Full Production Capacity

DanCann Pharma (SS:DANCAN)

Everything we do, we do for the patient and aeroponics enables us to deliver unspoiled products without any contamination or degradation from the irradiation process.”

— Morten Martinsen, Co-Founder, DanCannn Pharma

SANTA CLARA, CA, UNITED STATES, May 17, 2023/EINPresswire.com/ — AEssenseGrows, an AgTech company specializing in precision automated aeroponic platforms for software controlled high-yield plant production announced today, that DanCann Pharma, a medicinal cannabis company based in Denmark, is building out their entire capacity with 1, 2, and 4-Layer AEtrium Systems. With no deviations in their final Developmental inspection by the Danish Medicines Agency, DanCann plans for 80M DKK (~$11M USD) shipments to Germany and Poland from the immediate production ramp from 2023 to 2025.

“After finishing 3 grow cycles in our facility for validation, we will have qualified for commercial production with zero irradiation. This is pure and perfectly sterile aeroponic cannabis flower.”, said Morten Martinsen, Co-Founder and Head of Business Development, DanCann Pharma. “Everything we do, we do for the patient and aeroponics enables us to deliver unspoiled products without any contamination or degradation from the irradiation process.” Morten continued.

“The team at DanCann has crafted a completely unique grow recipe that we have not seen perfected by previous customers. Their method uses less than half the typical fertilizer content with amazing results.”, stated Michael Jorgensen, Managing Director, AEssenseGrows. “Their minimal salts aeroponic approach provides a very clean grow process with no biofilm build-up”, said Jorgensen.

DanCann has been testing many new strains over the last year with their favorites being Kush variants and several high THC hybrids and phenotypes. With standard operating procedures and workflows captured in the revolutionary Guardian Grow Manager software, DanCann has fingertip control over their entire scaled facility from one dashboard. The team expects to ramp output 20X over the next year. Already at full employment, full automation will allow the complete production ramp with minimal additional labor.

DanCann is producing pharma-grade premium cannabis for existing contracts. Current capacity, including the latest Double Deck AEtrium deliveries, is sold out through the end of 2024.

About AEssenseGrows
AEssenseGrows (pronounced “essence grows”), founded in 2014, is a precision AgTech company based in Santa Clara, CA. AEssenseGrows provides accelerated plant growth SmartFarm platforms and software automation delivering pure, zero pesticide, year-round, enriched growth to fresh produce and medicinal plant producers globally. With AEssenseGrows, you can precisely control your production operations at your fingertips from anywhere in the world. For more information, visit: https://www.AEssenseGrows.com

About DanCann Pharma
DanCann Pharma A/S (SS: DANCAN) was founded in 2018 and is a Danish biopharmaceutical company powered by cannabinoids. DanCann Pharma is a vertically integrated, licensed production and distribution company based in Denmark. The company focuses on discovering, developing, manufacturing, and commercializing new therapeutic cannabinoids in a wide range of disease areas.

DanCann Pharma A/S (SS:DANCAN) is listed on the Spotlight Stock Market in Stockholm/Copenhagen and on OTC Venture Market in the US (DCPXF). The corporate introduction video can be seen at: https://www.aessensegrows.com/aeroponic-medicinal-manufacturing-beyond-gmp-gacp-standards-dancann-pharma
For more information, visit: https://www.dancann.com

Disclaimer
Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events, or developments that the Company believes, expects, or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology.

Forward-looking statements are subject to several risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, the success of the Company’s research strategies, the applicability of the discoveries made therein, the successful and timely completion and uncertainties related to the regulatory process, the timing and outcomes of regulatory or intellectual property decisions and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities.

Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this presentation are made as of the date of this presentation and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Phil Gibson
AEssenseGrows
+ +1 669-261-3086
[email protected]
Visit us on social media:
Facebook
Twitter
LinkedIn
Instagram
YouTube
TikTok

DanCann Pharma: For those left behind

You just read:

News Provided By

May 17, 2023, 13:00 GMT


EIN Presswire’s priority is source transparency. We do not allow opaque clients, and our editors try to be careful about weeding out false and misleading content.
As a user, if you see something we have missed, please do bring it to our attention. Your help is welcome. EIN Presswire, Everyone’s Internet News Presswire™,
tries to define some of the boundaries that are reasonable in today’s world. Please see our
Editorial Guidelines
for more information.



Article originally published on www.einpresswire.com as DanCann Pharma in Multi-Level Expansion of Precision Aeroponic Systems to Fulfill Export Contracts

Business

Post navigation

Previous Post: Lamination Adhesives for Flexible Packaging Market Size to Reach USD 5420.30 Million in 2028: By Xcellent Insights
Next Post: War Day 297: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin

Related Posts

  • Trillium Announces Benjamin Baller to Be New Managing Director of Trading Business
  • Breast Cancer Liquid Biopsy Market Is Projected To Reach $357.05 Million by 2027 Business
  • Colle AI (COLLE) Sets the Stage for Major Enhancements Across Its Multichain AI & Web3 Platform Business
  • Gain Insights into the Investment Strategies of Industry Leaders Business
  • Fabular Holidays Launches B2B Travel Platform for Industry Professionals Business
  • The At-Home Genetic Testing Market Is Projected to Grow at a 15.5% CAGR by 2030
    The At-Home Genetic Testing Market Is Projected to Grow at a 15.5% CAGR by 2030 Business
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
« Oct    
last celebrity gossip
Gossip Stone - celebrity life and gossip

Recent Posts

  • Abdullah Al Junayed Releases Open Research Dataset on Machine FatigueNovember 18, 2026
  • The At-Home Genetic Testing Market Is Projected to Grow at a 15.5% CAGR by 2030November 17, 2026
  • MESSCAN Launches TC25 Compact Laser Distance Sensor for OEM Optical and Electro-Optical IntegrationNovember 17, 2026
  • The Assisted Reproductive Technology Market is to grow at a CAGR of 8.9%, reaching a value of $56.96 billion by 2030.November 16, 2026
  • Atopic Dermatitis Market Expected to Grow Steadily at a 14.6% CAGR Until 2030November 15, 2026
Brand Values Content
VUGA Enterprises - media network PR & Marketing
  • Secretary Blinken’s Call with South African Minister of International Relations and Cooperation Pandor World News
  • War Day 257: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin
    War Day 257: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin World News
  • Arsenic Market Size, Share And Growth Analysis For 2023-2032 World News
  • State of Russian Economy: GazProm Non-Profitable. Oil Drops. Sugar Exports Prohibition. Milov &Nacke World News
  • The impact of climate change on Greenland as the Arctic heats up – BBC News World News
  • Weather Risks Shouldn’t Deter Vacation Travel World News
  • Iran is experiencing human rights crisis with at least 300 killed, UN says – BBC News World News
  • Construction Chemicals Market Size Expected To Reach $77.77 Billion By 2028 World News
aerospace company
stem cell clinic in kiev
medical spa in miami
Fashion TV free

Copyright © 2026 195 News. All Rights Reserved by Coolaser

Powered by .